According to the public relations and information center of the Vice-Presidency for science and technology affairs, the call for the third national prize of stem cells and regenerative medicine is announced by the efforts of the stem cells sciences and technologies development headquarter.

The sections of this prize include top ideas, top articles, top thesis, and top invention. Enthusiasts of this field can send their works to the secretariat of the event until July 22nd 2018.

The national prize of stem cells and regenerative medicine has been held since 2015 to identify and motivate the activists of this field. In addition, winners of this round of the prize will be awarded on the third national festival and international congress of stem cells and regenerative medicine.

The inclusion criterion for the top idea section is being a student at the time of registration. The idea must be related to the fields and have the necessary innovative conditions. This section will have one winner. In the top article section, the applicants must be under 35 years at the time of registration. The articles must be authentic and their topics must be related to the field. The applicant must be the corresponding author and the first organizational dependence must be related to the first author. In addition, the article must be published during 2017-2018 and it should be indexed in the ISI database and its minimum impact factor must be two. This section of the event will have one winner.

The applicants must have at least two authentic articles extracted from their thesis and the impact factor of one of the articles must be above three and the second article must be published in journals with an impact factor above two. International patent registration is equal to an article with the impact factor of three. This section will have one winner.

The third national festival and international congress of stem cells and regenerative medicine will be held November 24th-December 1st, 2018 at the Iran International Conference Center and by the stem cells sciences and technologies development headquarter.